Podnos Yale 4
4 · Oncology Institute, Inc. · Filed Nov 18, 2024
Insider Transaction Report
Form 4
Podnos Yale
Chief Medical Officer
Transactions
- Other
Common stock
2024-11-12−11,359→ 93,009 total - Other
Common stock
2024-11-12−17,039→ 75,970 total
Footnotes (2)
- [F1]Reflects the forfeiture of restricted earn-out shares that were unvested due to failure to meet earnout targets of the Issuer's stock price of $12.50 per share for 20 days within any 30 consecutive trading days for the three-year period following November 12, 2021, the date of the closing of the Business Combination, subject to continued employment at such time.
- [F2]Reflects the forfeiture of restricted earn-out shares that were unvested due to failure to meet earnout targets of the Issuer's stock price of $15.00 per share for 20 days within any 30 consecutive trading days for the three-year period following November 12, 2021, the date of the closing of the Business Combination, subject to continued employment at such time.